Evidence map›Paper›PMID 12072567›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Mutually regulated expression of Pax6 and Six3 and its implications for the Pax6 haploinsufficient lens phenotype.

Guy Goudreau, Petros Petrou, Lixing W Reneker, Jochen Graw, Jana Löster, Peter Gruss

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. The Spectrum ofGenes · 2019
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Ocular surface development and gene expression.Journal of ophthalmology · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Guy GoudreauDepartment of Molecular Cell Biology, Max Planck Institute of Biophysical Chemistry, Am Fassberg, 37077 Göttingen, Germany.
Petros Petrou
Lixing W Reneker
Jochen Graw
Jana Löster
Peter Gruss
University of Missouri · USMax Planck Institute for Biophysical Chemistry · DE

Funding

Ras &PI 3-Kinase Signaling in Lens DevelopmentR01EY013146 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI RENEKER, LIXING W · 2001 to 2012
$2.6M
NEI NIH HHS EY13146NEI NIH HHS R01 EY013146
6 · The paper itself

Abstract

Pax6 is a key regulator of eye development in vertebrates and invertebrates, and heterozygous loss-of-function mutations of the mouse Pax6 gene result in the Small eye phenotype, in which a small lens is a constant feature. To provide an understanding of the mechanisms underlying this haploinsufficient phenotype, we evaluated in Pax6 heterozygous mice the effects of reduced Pax6 gene dosage on the activity of other transcription factors regulating eye formation. We found that Six3 expression was specifically reduced in lenses of Pax6 heterozygous mouse embryos. Interactions between orthologous genes from the Pax and Six families have been identified in Drosophila and vertebrate species, and we examined the control of Pax6 and Six3 gene expression in the developing mouse lens. Using in vitro and transgenic approaches, we found that either transcription factor binds regulatory sequences from the counterpart gene and that both genes mutually activate their expression. These studies define a functional relationship in the lens in which Six3 expression is dosage-dependent on Pax6 and where, conversely, Six3 activates Pax6. Accordingly, we show a rescue of the Pax6 haploinsufficient lens phenotype after lens-specific expression of Six3 in transgenic mice. This phenotypic rescue was accompanied by cell proliferation and activation of the platelet-derived growth factor alpha-R/cyclin D1 signaling pathway. Our findings thus provide a mechanism implicating gene regulatory interactions between Pax6 and Six3 in the tissue-specific defects found in Pax6 heterozygous mice.

Indexed as

Gene Expression Regulation, DevelopmentalPhenotypeAnimalsBase SequenceCyclin DCyclinsDNA PrimersDrosophila ProteinsElectrophoretic Mobility Shift AssayEye ProteinsHeterozygoteHomeobox Protein SIX3Homeodomain ProteinsImmunohistochemistryIn Situ HybridizationIn Situ Nick-End LabelingCycD protein, DrosophilaCyclin DCyclinsDNA PrimersDrosophila ProteinsEye ProteinsHomeobox Protein SIX3Homeodomain ProteinsNerve Tissue ProteinsPaired Box Transcription FactorsPax6 protein, mousePAX6 Transcription FactorReceptor, Platelet-Derived Growth Factor alphaRepressor Proteins

Identifiers

PMID12072567
PMCPMC124365
OpenAlexW2002996311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.